Clin2
NCT05331170Possibly a fitRecruiting

Re-training the nose to change how allergies behave

AsthmaAllergic RhinitisCat AllergyHealthy

Part of Ear, nose & throat, Immune system & allergy, Infections, Lungs & breathing clinical trials.

This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
75 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Be able to understand the study and sign informed consent, if you join
  • Be age 18 to 60
  • Do not have major chronic lung disease other than asthma (for the asthma group)
  • Be a non-smoker (or a very limited past smoker, quit at least 5 years ago)
  • For allergy groups: have allergy evidence to cat (blood test/skin test) plus regular cat exposure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00595491Recruiting· Phase 1
Study immune targets in cat and dust-mite allergic airway inflammation

This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.

Boston, Massachusetts
NCT06960382Recruiting· Phase 1/Phase 2
Cat allergy immunotherapy with lymph node injections

This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.

Zurich
NCT05009758Recruiting
Asthma and nasal polyps study to match immune patterns

This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.

Vienna
NCT06577077Not yet recruiting· Phase 3
Testing a new medicine for year-round allergies

This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.

NCT07675811Recruiting· Phase 3
Study of a new treatment for cat allergy related eye symptoms

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Andover, Massachusetts
NCT06999044Recruiting
Improving chronic rhinitis diagnosis with a nasal allergy test

This study uses a nasal allergen provocation test to help diagnose chronic rhinitis more accurately. If you have allergic rhinitis or are a healthy volunteer, you may help researchers learn how well this test works.

Nanjing, Jiangsu

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.